Medication info
Tenarican Tablet 20 mg (Teneligliptin Hydrobromide Hydrate)

Tenarican Tablet 20 mg (Teneligliptin Hydrobromide Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102864 · Approved 2021.04.01 · Insurance code 653405100

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine as monotherapy or in combination therapy is 20 mg once daily. It may be taken with or without food. When coadministered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood glucose control issues in patients with type 2 diabetes
View approved original text

This medication is used either as monotherapy or in combination with other medications, alongside dietary and exercise therapies, to help control blood glucose levels in patients with type 2 diabetes. It effectively aids in improving and managing blood glucose levels.

How to take

Adult dose

The recommended dose of this medicine as monotherapy or in combination therapy is 20 mg once daily. It may be taken with or without food. When coadministered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Precautions

This medication should not be administered to certain patients. For example, it is not appropriate for patients allergic to the main component or other ingredients, patients with type 1 diabetes, or those experiencing diabetic ketoacidosis or coma. Additionally, patients with severe infections, or those who have undergone surgery, or patients with severe trauma may not be suitable for this medication. Caution should be exercised when administering this medication to patients with severe liver dysfunction or heart failure; it is particularly not recommended for patients with severe heart failure. Patients taking sulfonylureas or insulin should also be careful. Patients at risk of hypoglycemia, such as those with pituitary or adrenal insufficiency, patients with poor nutritional status or irregular eating habits, those engaging in vigorous exercise, or those who consume excessive alcohol should be monitored closely. Patients with a history of abdominal surgery or bowel obstruction or those at risk of QT interval prolongation should also be cautious while using this medication. This medication may pose a risk of acute pancreatitis; thus, if symptoms like severe abdominal pain or vomiting occur, immediate medical attention is necessary. During the use of this medication, symptoms of hypoglycemia may arise, requiring the intake of carbohydrate-containing foods or glucose as needed. Caution is particularly needed when this medication is used in conjunction with other antihyperglycemic agents, as the risk of hypoglycemia may increase. Liver dysfunction, interstitial pneumonia, skin rashes, or vesicular diseases may occur; therefore, immediate consultation with a physician is advised if symptoms appear. Use of this medication during pregnancy is not recommended, and caution should be exercised during breastfeeding. Safety has not been established in children, and for elderly patients, who may have diminished physiological function, administration should be conducted while observing their condition. In case of overdose, gastrointestinal removal of the medication and clinical monitoring such as ECG tests should be carried out, and supportive treatment should be provided if necessary. This medication may interact with certain drugs; thus, particular attention should be given to monitoring blood glucose and patient condition when used with CYP3A4 inhibitors or medications that alter blood glucose-lowering effects. Finally, while taking this medication, caution is needed for activities requiring attention, such as driving or working at heights, considering the risk of hypoglycemia.

Side effects

  • Hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • herpes gestationalis
  • acute pancreatitis
  • dizziness
  • abdominal distention
  • abdominal discomfort
Show 145 more
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • appetite loss
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium levels
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • dyslipidemia
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • dizziness
  • upper respiratory tract infection
  • headache
  • tremors
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory tract infection
  • rhinitis
  • cold sweat
  • pruritus
  • diabetic retinopathy
  • vision loss
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intra-spinal disc protrusion
  • intra-spinal disc disorders
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urolithiasis
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyp
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • insomnia
  • urticaria
  • sensory disturbance
  • reduced sensation
  • tension-type headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • positional dizziness
  • muscle weakness
  • back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • vomiting
  • upper abdominal pain
  • odontalgia
  • gastrointestinal motility disorders
  • reduced gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • secondary mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • sputum abnormality
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip damage
  • bruise
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is air-tight, at room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.